Project Grant R01DA060898
Award Date 8/15/25
Completion Date 5/31/30
Dollars Obligated $804K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,746,930.00 to New York University School of Medicine to conduct a stepped wedge randomized controlled trial (RCT). The study aims to evaluate the impact of a technical assistance (TA) intervention designed to support permanent supportive housing (PSH) agencies in implementing evidence-based practices to reduce tenant overdose and...
- The University of Washington received a $777,497 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to conduct a hybrid implementation-effectiveness study of a pharmacist-led collaborative care model to improve access to hepatitis C treatment for people who use drugs with housing insecurity. The 5-year project aims to evaluate the reach, adoption, effectiveness, and maintenance of the "Pharmacist, Physician, Patient...
- This $572,229 federal Project Grant award from the U.S. Department of Housing and Urban Development (HUD), under the Continuum of Care (CoC) Program (CFDA 14.267), will fund efforts by the Public Health Management Corporation (PHMC), a non-profit organization based in Philadelphia, to quickly house homeless individuals and families while minimizing the trauma and dislocation caused by homelessness. The award supports a range of eligible activities under the CoC Program, including permanent...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $614,420 to the Hennepin Healthcare Research Institute (HHRI) to test the effectiveness of the Diabetes Homeless Medication Support (D-HOMES) program on improving glycemic control among adults living with type 2 diabetes who have experienced homelessness. The D-HOMES program...
- This $147,486 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a mixed-methods study examining the predictors and outcomes of methadone and buprenorphine receipt during incarceration. The study will analyze a longitudinal database on health service use and outcomes among 4,558 incarcerated individuals who received these medications from 2016-2023 at a unified jail and prison system in the Northeast....
- This federal Project Grant award from the National Institute of Nursing Research (NINR), under the Nursing Research program (CFDA 93.361), provides $691,485 to the University of Texas Health Science Center at Houston to conduct a 3-arm randomized clinical trial. The trial will evaluate an Employment-Based Housing (EBH) program integrated into a hospital emergency department as a multi-sectoral intervention to reduce acute care use and address social determinants of health for adults at risk of...
- This federal Project Grant award of $3,726,027, funded by the National Institute of Nursing Research (NINR) under the Nursing Research program (CFDA 93.361), aims to investigate the relationship between newly receiving U.S. Department of Housing and Urban Development (HUD) housing assistance and access to appropriate healthcare for adults with chronic health conditions. The grant was awarded to Drexel University, a private research university in Pennsylvania, with a performance period from...
- This federal Project Grant award of $770,461.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, titled "Police Pathways to Addiction Treatment, Health, and Safety: The Police PATHS Study", aims to investigate implementation gaps in police-assisted diversion (PAD) programs that link people who use drugs (PWUD) to treatment and services, especially medications for opioid use disorder. The project...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $194,903 to support research led by Dr. Ashish Thakrar at the University of Pennsylvania. The goal is to rigorously develop and evaluate a "loading dose" approach to initiating methadone treatment for hospitalized patients with opioid use disorder who are using the synthetic opioid fentanyl. This research aims to improve outcomes for...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...